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9 Summary 
10 Lactic acid bacteria (LAB), widely used as starter cultures for the fermentation of a large 
11 variety of food, can improve the safety, shelf life, nutritional value and overall quality of 
12 the fermented products. In this regard, the selection of strains delivering health-promoting 
13 compounds is now the main objective of many researchers. Although most LAB are 
14 auxotrophic for several vitamins, it is known that certain strains have the capability to 
15 synthesize B-group vitamins. This is an important property since humans cannot 
16 synthesize most vitamins, and these could be obtained by consuming LAB fermented 
17 foods. This review discusses the use of LAB as alternative to fortification by the chemical 
18 synthesis to increase riboflavin and folates concentrations in food. Moreover, it provides 
19 an overview of the recent applications of vitamin-producing LAB with anti-
20 inflammatory/antioxidant activities against gastrointestinal tract inflammation. This review 
21 shows the potential uses of riboflavin and folates producing LAB for the biofortification of 
22 food, as therapeutics against intestinal pathologies and to complement anti-
23 inflammatory/anti-neoplastic treatments.
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26 Introduction
27 Lactic acid bacteria (LAB) encompass a heterogeneous group of microorganisms having 
28 as a common metabolic property, the production of lactic acid as the majority end-product 
29 from the fermentation of carbohydrates (Hatti-Kaul et al. 2018; Takahashi et al. 2019). 
30 LAB are found in a large variety of nutrient-rich environments where carbohydrates and 
31 proteins are abundant (Vivek et al. 2019). LAB are Gram (+), non-sporulating, catalase 
32 negative, acid-tolerant, facultative anaerobic organisms. Except for a few species, LAB 
33 members are nonpathogenic organisms with a reputed Generally Recognized As Safe 
34 (GRAS) status. Many species are used for the manufacture and preservation of 
35 fermented feed and foods from raw agricultural materials in which they are either present 
36 as contaminants or deliberately added as starter cultures. Enzymatic activities of these 
37 microorganisms contribute to the final organoleptic, rheological and nutritional properties 
38 of fermented products (dos Santos Cruxen et al. 2019).
39 Some LAB strains have been shown to possess health-promoting functions such as 
40 immunomodulation, improvement of intestinal integrity, pathogens resistance, prevention 
41 of lactose intolerance, anticarcinogenic effects, reversal of depression and anxiety 
42 symptoms, anti-obesity and anti-diabetic activities and reduction of serum cholesterol 
43 levels (de Melo Pereira et al. 2018). Due to their safety and beneficial effects on health, in 
44 addition to their biotechnological potential (Capozzi et al. 2012), many strains of LAB can 
45 be considered probiotics which are defined as "live microorganisms that when 
46 administered in adequate amounts, confer a health benefit to the host" (WHO 2002).
47 In addition to their intrinsic properties, certain strains of LAB have the capability of 
48 producing /releasing and/or increasing specific beneficial compounds in foods. While LAB 
49 are usually auxotrophic for several vitamins, it has been reported that certain strains have 
50 the ability to synthesize B group vitamins (riboflavin, folates, thiamine and cobalamin) 
51 (LeBlanc et al. 2011). 
52 Vitamins are organic compounds necessary for many physiological functions essential for 
53 life. Unlike other nutrients, vitamins neither fulfill structural functions nor are they an 
54 energy source; they act as enzymatic cofactors, participate in oxide-reduction metabolic 
55 reactions or act as hormones (Combs Jr, 2012). Certain vitamins, such as folates have 
56 even been considered functional food constituents due to their biological functions (Iyer 
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58 diets are an important cause of deficiencies, present in all parts of the world (LeBlanc et 
59 al. 2011). For this reason, vitamin-producing microorganisms could be used to produce 
60 foods with high concentrations of natural forms of vitamins and avoid undesirable side 
61 effects associated to chemical vitamins normally used for food fortification (FAO/WHO, 
62 2005). In addition, bio-fortified foods represent a less expensive alternative than 
63 fortification and could help consumers meet their daily recommended intakes (LeBlanc et 
64 al. 2013). In addition, consumers currently tend to choose foods that not only provide 
65 nutrients but also have additional properties that benefit their health (Burgess et al. 
66 2004). In this sense, LAB that produce vitamins have the advantage of increasing the 
67 nutritional value of a food (LeBlanc et al. 2013). The chemical synthesis of a vitamin, 
68 such as riboflavin, can be replaced by fermentation processes, showing economic and 
69 environmental advantages, in addition that microbial synthesis uses of renewable 
70 sources, is more ecological and achieve high quality end products (Thakur et al. 2016b, 
71 Zhu et al. 2020).
72 This review will discuss the use of LAB as a natural alternative to increase riboflavin and 
73 folates concentrations in foods and provide an overview of the recent applications of LAB 
74 as a source of vitamins with anti-inflammatory/antioxidant activities against 
75 gastrointestinal tract (GIT) inflammation.
76
77 Methods
78 The authors have searched relevant literature in the electronic databases of the U.S. 
79 National Library of Medicine (Pubmed) and Google Scholar, by the use of the following 
80 search terms: lactic acid bacteria, riboflavin, folates, vitamins, probiotic, intestinal 
81 inflammation, inflammatory bowel disease and intestinal mucositis. No double-reviewed 
82 studies, issued in a language other than English and published before 1990 were 
83 excluded. Works published between 1990 and 2020, and one official web-site were 
84 extracted as fulfilling the inclusion criteria.
85
86 Riboflavin-producing LAB
87 Riboflavin (vitamin B2) is the precursor of flavin mononucleotide (FMN) and flavin 
88 adenine dinucleotide (FAD), two coenzymes that play a central role in metabolism by 









This article is protected by copyright. All rights reserved
90 Riboflavin is a key nutrient for all aerobic forms of life, essential for normal cellular 
91 functions and growth (Aili et al. 2013). Although riboflavin is found in a variety of foods, 
92 suboptimal intakes can lead to ariboflavinosis. Riboflavin deficiency is associated with 
93 eye-related problems, cardiac risk, preeclampsia, anemia, liver and skin damage and 
94 changes in cerebral glucose metabolism (Levit et al. 2018a).
95 In addition to the fortification of foods with chemically synthesized vitamin, the use of 
96 riboflavin-producing microorganisms, as was explained above, has gained importance in 
97 recent years as a biofortification strategy. This is due to its economic advantages 
98 compared to the chemical synthesis process added to the ”nature-friendly” characteristics 
99 of the fermentation process (Thakur et al. 2016b; Revuelta et al. 2017). 
100 Riboflavin is synthesized in seven enzymatic stages from guanosine triphosphate (GTP) 
101 and d-ribulose-5-phosphate precursors (Bacher et al. 2000) (Figure 1), and the synthesis 
102 is strain dependent.
103 Some LAB strains are able to synthesize riboflavin and their use during fermentation 
104 improves the nutritional value of foods (Table 1). Furthermore, riboflavin concentrations 
105 can sometimes vary in certain products due to processing technologies and the action of 
106 the microorganisms utilized during food processing. In this regard, it was shown that the 
107 addition of supplements, such as dietary fibers from fruit sources can increase riboflavin 
108 production (Albuquerque et al. 2020). 
109 Riboflavin-producing LAB have been isolated from different ecological niches and 
110 showed the ability to increase the concentrations of this vitamin in food matrices such as 
111 milk, soymilk, whey and pseudocereals (Ewe et al. 2010; Juarez del Valle et al. 2014; 
112 Thakur et al. 2016a, Rollán et al. 2019). Recently, it was reported the riboflavin 
113 fortification of different kefir-like cereal-based beverages using selected LAB strains 
114 (Yépez et al. 2019).
115 Furthermore some bacteria are capable of riboflavin overproduction (Burgess et al. 
116 2009). This trait can be achieved either by metabolic engineering (Jiménez et al. 2005) or 
117 by exposure to purine analogues and/or the toxic riboflavin analogue roseoflavin (Perkins 
118 et al. 1991). Particularly, in Lactococcus (L.) lactis both of these approaches have been 
119 used with success (Burgess et al. 2004). Recent studies have reported on the selection 
120 of riboflavin-overproducing strains for potential food applications, for example, the 
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122 found to improve the riboflavin status of deficient rats (LeBlanc et al. 2006). These strains 
123 are acceptable by the consumer because they are not considered genetically modified. 
124 Natural strains overproducing riboflavin obtained by exposure to roseoflavin, a riboflavin 
125 toxic analog, were used to obtain bioenriched bread, pasta and soymilk (Capozzi et al. 
126 2011; Juarez del Valle et al. 2014; Russo et al. 2014). This strategy allows increasing the 
127 nutritional value of these foods, for example in the case of soymilk. This matrix is rich in 
128 proteins and contains high levels of unsaturated fatty acids; the fermentation with 
129 riboflavin-overproducing strains was used to obtain a bio-enriched food with improved 
130 nutritional, organoleptic and sensorial properties (Juarez del Valle et al. 2014). 
131 Furthermore the bioavailability of riboflavin produced by some LAB has been 
132 demonstrated in different animal models (LeBlanc et al. 2005; Juarez del Valle et al. 
133 2016; Carrizo et al. 2020). On the other hand, metabolic engineering was used to 
134 construct recombinant strains and also to improve the riboflavin production (Koizumi et al. 
135 2000; Burgess et al. 2004; Jayashree et al. 2011). Genetically modified L. lactis has been 
136 shown to be efficient in reverting riboflavin deficiencies in rodents (LeBlanc et al. 2005a; 
137 LeBlanc et al. 2005b). In these studies, it was shown that the administration of 
138 spontaneous and engineered L. lactis that overproduces riboflavin and a milk fermented 
139 by these strains was able to eliminate most physiological manifestations of 
140 ariboflavinosis, such as stunted growth, elevated erythrocyte glutathione reductase 
141 activation coefficient values and hepatomegaly in depleted rats. These findings were 
142 similar to those obtained with commercial riboflavin whereas a non riboflavin-producing 
143 strain did not show beneficial results (LeBlanc et al. 2005). Furthermore, the 
144 administration of soymilk bio-enriched with riboflavin produced by Lactobacillus (Lact.) 
145 plantarum CRL 2130 was able to revert riboflavin deficiency in depleted mice as 
146 evidenced by normal growth, riboflavin status and morphology of the small intestines. 
147 The same tendency it was observed in a prevention model where mice did not show 
148 signs of riboflavin deficiency (Juarez del Valle et al. 2016). Another study showed that the 
149 administration of pasta made with quinoa sourdough and fermented by Lact. plantarum 
150 strains that produce both vitamins B2 and B9 was able to increase the levels of these 
151 vitamins in mice blood compared to depleted animals, similar to the results obtained in 
152 animals that received pasta supplemented with commercial vitamins (Carrizo et al. 2020). 
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154 synthetic vitamins and it could be useful to prevent vitamins deficiency. In another study, 
155 as many as 60 lactobacilli were screened for the ability of riboflavin overproduction via 
156 screening of the genes responsible for riboflavin synthesis by a PCR-based method 
157 (Thakur et al. 2016c). Among the lactobacilli screened, the presence of genes 
158 responsible for riboflavin synthesis was strain-specific across different species. The 
159 isolates possessing incomplete rib structural genes could not survive in the riboflavin-
160 deficient medium. On contrary, the isolates KTLF1 (Lact. fermentum) KTLP13 (Lact. 
161 plantarum) and KTLF3 (Lact. fermentum) were not only able to grow well on riboflavin-
162 deficient medium agar but also supported the growth of the riboflavin auxotroph strain 
163 (Liu et al. 2020). 
164
165 Folates-producing LAB
166 The generic term folates or vitamin B9/B11 is used to describe folic acid and related 
167 compounds that exhibit the same biological activity. This vitamin is involved in numerous 
168 vital biological reactions, including DNA synthesis and methylation, and participates in the 
169 synthesis of some amino acids, nucleotides and other vitamins (Nazki et al. 2014). 
170 Folates possess antioxidant properties that protect the genome by inhibiting free radical 
171 attack of DNA, in addition to their role in DNA repair and replication mechanisms (Duthie 
172 et al. 2002). Folates are key nutrients for human health and for ensuring normal 
173 development, growth, and the maintenance of optimal health (Bailey et al. 2015). Folates 
174 deficiency causes severe abnormalities in one-carbon metabolism, which is considered 
175 risk factor for some chronic diseases and developmental disorders, including autism 
176 (Lyall et al. 2014), Alzheimer's disease (Hinterberger and Fischer 2013), senile dementia 
177 (mental deterioration in old age) (Araújo et al. 2015), and neural tube defects (NTDs) 
178 (Copp et al. 2013). 
179 Although folates are present in various foods, the intake of this vitamin through the diet 
180 may be insufficient to meet daily requirements. To address this problem, foods fortified by 
181 addition of folic acid have been developed. Unfortunately, food fortification with synthetic 
182 molecules may present some downsides. It has been shown that the absorption of high 
183 amounts of folic acid can mask the symptoms of vitamin B12 deficiency, which may result 
184 in the progression of neuropathy to an irreversible point (FAO/WHO, 2005). Furthermore, 
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186 reductase enzymatic activity in the liver (Bailey and Ayling 2009). Therefore several 
187 studies seem to raise doubts about the safe use of the chemically synthetized folic acid in 
188 foods (Saubade et al. 2017), addressing the fortification through biological approaches 
189 (Rad et al. 2016). In this sense the use of natural folates could represent an alternative to 
190 synthetic folic acid to avoid the adverse effects associated with its consumption 
191 (Scaglione and Panzavolta 2014).To this regard, some species of LAB are able to 
192 accumulate folates (see biosynthetic pathway in Figure 2) in different substrate after a 
193 fermentation process (Table 2). However, the ability of microorganisms to produce folates 
194 is strain-specific and influenced by the growth conditions (Laiño et al. 2013; Kariluoto et 
195 al. 2014; Laiño et al. 2015; Saubade et al. 2017). In this sense, a preview review 
196 discussed that folates production can also be affected by symbiosis between starter 
197 cultures, the presence of prebiotics, the external pH of the growth media (food), 
198 incubation temperature and the presence of the chemical precursors guanosine 
199 triphosphate (GTP) and 4-aminobenzoate, a product of shikimate biosynthesis pathway 
200 (Savoy de Giori and LeBlanc, 2018).
201 It was previously believed that Streptococcus (Strep.) thermophilus are folates producers 
202 while Lact. delbrueckii subsp. bulgaricus utilize folates for their growth. However, Laiño et 
203 al. (2012) found that some strains of Lact. delbrueckii subsp. bulgaricus, isolated from 
204 artisanal Argentinean fermented dairy products, were able to grow in a folates-free 
205 culture medium and to produce high folates levels. It was demonstrated that Lact. 
206 bulgaricus CRL 871 was able to synthesize both intra-and extra-cellular folates. This 
207 strain inoculated with Strep. thermophilus (CRL 803 and CRL 415) produced a yogurt 
208 naturally bio-enriched in folates with a four-fold increase in vitamin content compared to 
209 unfermented milk and a two-fold increase compared to conventional yogurts (Laiño et al. 
210 2013). It has been also demonstrated that the addition of Lact. amylovorus CRL 887 to 
211 this yogurt starter culture was efficient in producing a yogurt with even higher folates 
212 concentrations (six-fold increase, 260 µg l-1) making this new bio-enriched product a very 
213 interesting alternative to fortification with chemical folic acid (Laiño et al. 2014). A recent 
214 study combined five Strep. thermophilus strains with Lact. plantarum 16cv, and the 
215 combination that produced the highest levels of folates was used for preparation of 
216 bioenriched fermented milk under controlled conditions (pH 6.0, 42 °C, 70 rpm, 24 h). 









This article is protected by copyright. All rights reserved
218 were demonstrated in a depletion/repletion mice model (Cucick et al. 2020). Some 
219 folates-producing strains were also able to increase the concentration of this vitamin in 
220 goat's milk (Da Silva et al. 2016). Several studies showed that LAB strains, isolated from 
221 cereals and seeds, were also able to overproduce folates leading to a bioenriched end 
222 product (Salvucci et al. 2016; Carrizo et al. 2016). Furthermore, Lact. plantarum CRL 
223 2106 and CRL 2107 synthesized the highest concentration of folates during amaranth 
224 sourdough demonstrating the potential of LAB to improve the nutritional and functional 
225 values of pseudocereal-derived foods (Carrizo et al. 2017). Fermentation process of oats 
226 and soybean with LAB to improve folates content was also successful (Kariluoto et al. 
227 2014; Carrizo et al. 2020). Lact. rhamnosus LGG and Strep. thermophilus TH-4, used as 
228 culture starter for fermented soymilk production, were able to produce folates. Also, the 
229 addition of passion fruit by-product and fructooligosaccharides stimulated the folates 
230 production by these strains during fermentation process (Albuquerque et al. 2017). 
231 Moreover, LAB strains isolated from a traditional Andean fermented potato product, 
232 tocosh, were selected to ferment tubers-oca, papalisa and potato supplemented with 
233 amaranth and chia flour and a product with high folates content and nutritional value was 
234 obtained (Mosso et al. 2018). 
235 It was also demonstrated that folates production may be influenced by nutritional and 
236 environmental conditions. In this regard, different parameters such as the fermentation 
237 period, temperature, concentration of precursors such as para-aminobenzoic acid (pABA) 
238 and glutamate, prebiotics and reducing agents influenced the production and 
239 bioavailability of this vitamin in skim milk and fruit juices (Gangadharan and Nampoothiri 
240 2011). It was also demonstrated that passion fruit by-products and fructooligosaccharides 
241 increased the folates production in soymilk by selected bacterial strains (Albuquerque et 
242 al. 2017). Recently, an increase in folates content has been observed by Thompson et al. 
243 (2020) in a cauliflower-white beans mixture after fermentation with Lact. plantarum 
244 strains. The genes for folates biosynthesis have been identified in this species 
245 (Kleerebezem et al. 2003). In the last year, it was reported that all of the genes encoding 
246 enzymes involved in the folates biosynthesis pathway in Lact. plantarum strain 4_3 
247 genome sequences were expressed and detected in transcriptomic data throughout the 
248 culture period in folic acid casei medium (FACM) and fermented soybean (Liu et al. 
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250 chorismate, pABA, and THF–polyglutamate biosynthesis) were expressed at different 
251 levels in both media. This strain grew slower in fermented soybean than in FACM, which 
252 was confirmed by the final pH values of the media and the transcriptomic patterns. 
253 However, the high folates production in fermented soybean could be explained by the 
254 high expression of the de novo biosynthesis genes in the para-aminobenzoate pathway.
255 Moreover, it is known that hyperhomocysteinemia is associated to folates deficiency. 
256 Recently a study performed in hyperhomocysteinemic mice, showed that 
257 supplementation with folates-enriched fermented milk (folates-producing strains: Strep. 
258 thermophilus 563 and Lact. delbrueckii subsp. lactis 1021 used as starter) restored 
259 homocysteine and S-adenosyl-methionine levels in folates deficient mice (Zinno et al. 
260 2020). 
261
262 Vitamin production by LAB to counteract intestinal inflammation
263 This review summarizes the studies concerning the effect of vitamin-producing   LAB 
264 against intestinal inflammation in pathologies such as inflammatory bowel diseases and 
265 intestinal mucositis.
266 Inflammatory bowel diseases (IBD) are a group of chronic disorders characterized by 
267 inflammation of the GIT. Crohn's disease (CD) and ulcerative colitis (UC), the two main 
268 manifestations of IBD, share common characteristics but exhibit physiopathological 
269 differences (Yangyang and Rodriguez 2017). Successful management of IBD includes 
270 pharmacological, surgical and nutritional therapies. Some studies have shown that a 
271 large percentage of patients with IBD have nutritional deficiencies, mainly of vitamins and 
272 minerals (iron, vitamin B12, vitamin D, vitamin K, folates, selenium, zinc, vitamin B6 and 
273 vitamin B1) (Montgomery et al. 2015; Weisshof and Chermesh 2015). For this reason, 
274 patients with IBD under treatment frequently receive nutritional supplementation to 
275 correct deficiencies of macro and micronutrients and receive extra calories and proteins 
276 to maintain a positive nitrogen balance and thus promote mucosal healing (Martínez 
277 Gómez et al. 2016). 
278 Another intestinal inflammatory condition is mucositis, a severe inflammation of the 
279 gastrointestinal mucosa that occurs, among other causes, as a result of cancer 
280 treatments. In general terms, antineoplastic therapies damage the mucous membranes 
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282 nutrients and the intestinal barrier. This can cause malnutrition and bacterial translocation 
283 contributing to systemic inflammation that is associated with the morbidity and/or 
284 mortality of cancer patients (Vanhoecke et al. 2015). Because of malnutrition, many 
285 patients undergoing chemotherapy treatment often take nutritional supplements and 
286 receive mega vitamin therapy (Branda et al. 2004).
287 LAB have shown that can counteract inflammatory processes in the GIT through different 
288 mechanisms, this was demonstrated using animals models of IBD and intestinal 
289 mucositis (IM) and in clinical trials, being the intestinal microbiota and host’s immune 
290 response modulation the most evaluated (dos Santos et al. 2016; Ferreira dos Santos et 
291 al. 2016; Tang et al. 2017; Yokota et al. 2018; Choi et al. 2019).
292 LAB can also produce different vitamins, and some vitamins’ supplementation have 
293 proven to be  effective against intestinal inflammation; so vitamin production has also 
294 been associated to the anti-inflammatory properties of certain LAB, in addition to the 
295 nutrition value of these strains, against intestinal pathologies (Table 3). 
296 Recent studies about the effect of vitamin-producing LAB on intestinal inflammation are 
297 summarized below. A riboflavin-overproducing strain, Lact. plantarum CRL 2130, 
298 attenuated the chemical induced intestinal inflammation in mice, in a similar way as the 
299 commercial riboflavin, which was used as a control. These benefits were obtained when 
300 the LAB was administered in a fermented aqueous soy extract or as a bacterial 
301 suspension. The administration of the unfermented aqueous soy extract or fermented 
302 with a non  riboflavin-producing strain did not show the anti-inflammatory effect, 
303 demonstrating that the benefit of LAB against colitis was due to the riboflavin production 
304 (Levit et al. 2017a; Levit et al. 2017b). It should be noted that the non-riboflavin-producing 
305 strain used in this study is not an isogenic strain of Lact. plantarum CRL 2130, so it is 
306 possible that both are genetically and phenotypically different; and these differences 
307 could affect the response in the host, regardless of riboflavin production. A strain of Lact. 
308 plantarum CRL 2130 in which riboflavin biosynthesis genes are non-functional should be 
309 used in future studies to avoid the possible effect of the genetic background. 
310 In addition, in vitro assays demonstrated that this strain exerted a protective mechanism 
311 against oxidative stress (Levit et al. 2018b). The anti-oxidant/anti-inflammatory effects of 
312 Lact. plantarum CRL 2130 were also evaluated in a mouse model of intestinal mucositis. 
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314 damages associated with 5-fluorouracil (5-FU) induced IM (Levit et al. 2018b). In this 
315 study, authors used Lact. plantarum CRL 725 as control. This is the bacterial strain from 
316 which Lact. plantarum CRL 2130 was derived, after exposing it to roseoflavin, so the only 
317 difference between both strains is the amount of riboflavin produced. The lack of effect 
318 reported from mice administered Lact. plantarum CRL 725 showed that riboflavin was 
319 associated to the anti-inflammatory effect attributed to Lact. plantarum CRL 2130. 
320 Regarding folates, a folates-producing strain, Strep. thermophilus CRL 808, was also 
321 effective in preventing IM induced by  5-FU in mice. Administration of this folates-
322 producing strain showed an anti-inflammatory effect similar to commercial folic acid that 
323 was used as a control. (Levit et al. 2018c). 
324 In order to improve the individual properties of these two vitamin-producing strains, they 
325 were mixed with Strep. thermophilus CRL 807, a LAB with immunomodulatory properties 
326 (del Carmen et al. 2014). This bacterial blend was studied as a complement to the 
327 conventional treatment against chronic inflammation. The bacterial mixture was 
328 administered to mice with chronic colitis during the remission period together or not with 
329 the anti-inflammatory drug mesalazine. The anti-inflammatory effect of the bacterial blend 
330 was by attenuating the symptoms after inducing the recurrence of inflammation. It is 
331 important to highlight that the selected LAB mixture did not affect the primary treatment in 
332 mice that received the anti-inflammatory drug; however, prevented undesirable side 
333 effects induced by the chronic treatment with mesalazine (Levit et al. 2019).
334 All these reports demonstrate that the use of vitamin-producing LAB could represent a 
335 potential tool to reduce inflammation in patients with intestinal pathologies and to provide 
336 patients with essential nutrients that are normally deficient in these diseases; however, 
337 future studies are need in order to elucidate the exact mechanism by which these 
338 vitamin-producing strains exert their benefits.
339
340 Conclusions
341 This review summarized the use of LAB that produce riboflavin or folates for food 
342 biofortification as a natural and more economical alternative than fortification by chemical 
343 synthesis. This would enable the food industry to produce foods with high concentrations 
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346 Taking into account that consumers demand foods that in addition to providing nutrients 
347 have some health benefits, this review provided an overview of recent studies where 
348 vitamin-producing LAB were shown to counteract inflammatory processes in the GIT and 
349 to complement anti-inflammatory/anti-neoplastic treatments (Figure 3). From these 
350 studies, vitamin-producing LAB have the potential to improve the effects and/or to reduce 
351 the unwanted side effects associated with conventional treatments as well as represent a 
352 source of vitamins for these patients that usually have nutritional deficiencies. In this 
353 sense, vitamin-producing LAB could be used as adjunct treatments and eliminate the 
354 need of using synthetic forms of vitamins (such as folic acid) that have been shown to 
355 cause unwanted side effects. 
356
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715 Figure 1: Riboflavin biosynthesis pathway in lactic acid bacteria
716
717 Figure 2: Folates biosynthesis pathway in lactic acid bacteria
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719 Figure 3: Vitamin-producing lactic acid bacteria can be used in the industry for food 
720 biofortification (riboflavin and folates) and as probiotics to counteract inflammatory 














Table 1 Examples of LAB strains with ability of increasing the riboflavin 











Lact. acidophilus ATCC 314 soymilk   6.57±0.36 mg l-1 Ewe et al. 2010 
Lact. acidophilus FTDC 8833 soymilk  2.43±0.05 mg l-1 Ewe et al. 2010 
Lact. acidophilus FTDC 8633 soymilk 1.13±0.02 mg l-1 Ewe et al. 2010 
Lact. plantarum CRL 725 soymilk 
700.00±20.00 ng 
ml-1  
Juarez del Valle et 
al. 2014 
Lact. platarum CRL 725 (G) soymilk 
1860.00±20.00 ng 
ml-1  
Juarez del Valle et 
al. 2014 
Lact. fermentum KTLF1 milk 1.50 mg l-1 Thakur et al. 2016a 
Lact. muocase KTLF5 whey 0.83 mg l-1 Thakur et al. 2016a 
Lact. plantarum M5MA1-B2 
maize kefir-
like 
0.50 mg l-1 Yepéz et al. 2019 
Lact. plantarum M5MA1-B2 oat kefir-like 1.50 mg l-1 Yepéz et al.2019 
Lact. plantarum  UNIFGPL104 
and UNIFGPL209 
bread  6.81 μg g-1 Capozzi et al. 2011 
Lact. plantarum  UNIFGPL104 
and UNIFGPL209 
pasta  4.01 μg g-1 Capozzi et al. 2011 
 
 
Table 2 Examples of LAB strains with ability of increasing the folates 











Strep. thermophilus CRL 803 nonfat milk 60.00-80.00 µg l-1 
Laiño et al. 
2012 
Strep. thermophilus 908 nonfat milk 
76.61±3.29 ng ml-
1 
Meucci et al. 
2018 




Strep. gallolyticus subsp. 
macedonicus CRL 415 
nonfat milk 60.00-80.00 µg l-1 Laiño et al. 
2012 
Lact. delbrueckii subsp. 
bulgaricus CRL 863 
nonfat milk 60.00-80.00 µg l-1 Laiño et al. 
2012 
Strep. thermophilus CRL 803, 
Lact. delbrueckii subsp. 
bulgaricus CRL 871, and Strep. 
gallolyticus subsp. macedonicus 
CRL 415 
yogurt 180.00±10.00 µg 
l-1 
Laiño et al. 
2013 
Strep. thermophilus CRL 803, 
Lact. delbrueckii subsp. 
bulgaricus CRL 871, Lact. 
amylovorus CRL 887, and Strep. 





Laiño et al. 
2014 
Strep. thermophilus TH-4 and 
Lact. rhamnosus LGG 






et al. 2017 
 
Lact. plantarum P2R3FA 
wheat-based 
fermented bread 
43.10±3.20 µg l-1 
Tamene et al. 
2019 
Lact. plantarum CRL2106 and 




Carrizo et al. 
2017 
Lact. plantarum CRL 2107 and 
Lact. plantarum CRL 1964 
quinoa sourdough 1.60±0.20 µg g-1 
Carrizo et al. 
2020 
Lact. sakei CRL 2210 
 
tuber puree with 
amaranth and chia 
flour 
1.90 µg g-1 
Mosso et al. 
2018 
Lact. sakei CRL 2209 and Lact. 
sakei CRL 2210 
andean tuber purees 
730.00-1484.00 
ng g-1 
Mosso et al. 
2018 
L. lactis subsp. lactis FP368 goat milk 
313.00±81.00 µg 
l-1 
Da Silva et 
al. 2016  




et al. 2011 




et al. 2011 
 
 
Table 3 Examples of beneficial effects of folates and riboflavin-producing LAB strains 
Strains / product 
Vitamin 
produced 
Beneficial effect Host /model References 
Lact. plantarum CRL 2130  riboflavin Normalization of the intestinal morphology (villus size) Riboflavin-depleted mice 
Juarez del 
Valle et al. 
2016 
Lact. plantarum CRL 2130 / 
fermented soy milk 
riboflavin 
Reduction of IBD features (weight loss, intestinal 
inflammation, microbial translocation to liver and cytokines 
in intestinal fluids) 
2,4,6-trinitrobenzene 
sulphonic acid (TNBS)- 
induced mice 
Levit et al. 
2017b 
Lact. plantarum CRL 2130, Lact. 
paracasei CRL 76, Lact. 
bulgaricus CRL 871 or Strep. 
thermophilus CRL 803 
riboflavin 
Reduction of IBD features (intestinal inflammation, 
microbial translocation to liver, inducible nitric oxide 
synthase (iNOSs) enzyme producing cells, pro- 
inflammatory cytokines in intestinal fluids) 
TNBS- induced mice 
Levit et al. 
2017a 
Lact. plantarum CRL 2130 riboflavin 
Reduction of intestinal mucositis (IM) features (diarrhea, 
alterations in the architecture of the small intestine, pro- 
inflammatory cytokines in serum and in intestinal fluids) 
5-Fluorouracil (5-FU)- 
induced mice 
Levit et al. 
2018b 
Lact. reuteri ATCC PTA 6475 folates 
Reduction of IBD features (macroscopic intestinal 
inflammation, weight loss, serum amyloid protein A) 
TNBS- induced mice 
Thomas et al. 
2016 
Strep. thermophilus CRL 808 folates 
Reduction of IM features (diarrhea, alterations in the 
architecture of the small intestine, pro- inflammatory 
cytokines in serum) 
5-FU- induced mice 







Strep. thermophilus 34v and Lact. 
plantarum16cv / fermented milk 
folates 
Improve of hematological parameters and villi height/crypt 
depth ratio in the small intestine  
Folates-depleted mice 
Cucick et al. 
2020 
Lact. plantarum CRL 2130, Strep. 
thermophilus CRL 808 and Strep. 
thermophilus CRL 807 
riboflavin- 
folates 
Reduction of chronic IBD features (intestinal inflammation, 
and pro- inflammatory cytokines in intestinal fluids) and 
prevention of side effects of chronic anti- inflammatory 
therapy 
TNBS- induced mice Levit et al. 2019 
Lact. plantarum CRL 2107 and 




Normalization of the intestinal morphology (number and 
length of villi) 
Folates and riboflavin- 
depleted mice 
Carrizo et al. 
2020 
5-Amino-6-ribosilamino-2,4








4(3H)- pyrimidone- 5 ‘-phosphate
5-Amino-6-ribitylamino-2,4 















































































pool of  folates
1 GTP cyclohydrolase I (EC 3.5.4.16)
2 phosphatase (EC 3.6.1.-)
3 alkaline phosphatase (EC 3.1.3.1)
4 dihydroneopterin aldolase (EC 4.1.2.25)
5 dihydropteridinhydroxymethyl pirophosphokinase (EC 2.7.6.3)
6 aminodeoxychorismate synthetase (EC 2.6.1.85)
7 aminodeoxychorismate lyase (EC 4.1.3.38)
8 dihydropteroate synthetase (EC 2.5.1.15)
9 dihydrofolate synthetase (EC 6.3.2.12
10 dihydrofolatoreductase (EC 1.5.1.3)
11 γ-glutamyl hydrolase (EC 3.4.19.9)
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